Featured Research

from universities, journals, and other organizations

New Vaccine That Protects Monkeys Against Avian Flu Ready For Human Trials

Date:
November 9, 2007
Source:
American Society for Microbiology
Summary:
A new vaccine that protects monkeys against the avian influenza virus is now a candidate for clinical trial in humans. The rate of transmission of the highly pathogenic avian influenza virus (HPAIV) from birds to humans is rapidly increasing. The H5N1 strain is responsible for 278 known human infections resulting in 168 deaths.

Colorized transmission electron micrograph of Avian influenza A H5N1 viruses (seen in gold) grown in MDCK cells (seen in green).
Credit: CDC/ Courtesy of Cynthia Goldsmith, Jacqueline Katz, and Sherif R. Zaki

Researchers from the National Institutes of Health and University of Maryland report that a new vaccine that protects monkeys against the avian influenza virus is now a candidate for clinical trial in humans. The rate of transmission of the highly pathogenic avian influenza virus (HPAIV) from birds to humans is rapidly increasing.

Related Articles


The H5N1 strain is responsible for 278 known human infections resulting in 168 deaths. The possibility of a pandemic outbreak emphasizes the need for an effective vaccine, however development has been impeded by factors such as poor immunogenicity, biosafety concerns, and risk of genetic exchange with circulating influenza virus strains.

In the study researchers developed a live vaccine incorporating the avian Newcastle disease virus (NDV), which expresses a common gene found in the H5N1 avian influenza virus, and tested it in African monkeys. The vaccine was administered both intranasally and through the respiratory tract in two doses with a 28-day interval in between.

Response after one dose showed low amounts of virus shedding indicating protection. Following two doses, high levels of neutralizing antibodies were present in all immunized monkeys. A substantial response to either dosage was noted in the respiratory tract indicating a likely reduction in transmission in the event of an outbreak.

"In this study, we have developed a vaccine candidate, NDV-HA, for immunization against H5N1 HPAIV and have tested it in a nonhuman primate model," say the researchers. "The vaccine was well tolerated and induced substantial local and systemic immune responses, demonstrating that NDV has potential as a live virus candidate vaccine against HPAIV."

Journal reference: J.M. DiNapoli, L. Yang, A. Suguitan Jr., S. Elankumaran, D.W. Dorward, B.R. Murphy, S.K. Samal, P.L. Collins, A. Bukreyev. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. Journal of Virology, 81. 21: 11560-11568.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Microbiology. "New Vaccine That Protects Monkeys Against Avian Flu Ready For Human Trials." ScienceDaily. ScienceDaily, 9 November 2007. <www.sciencedaily.com/releases/2007/11/071108180449.htm>.
American Society for Microbiology. (2007, November 9). New Vaccine That Protects Monkeys Against Avian Flu Ready For Human Trials. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2007/11/071108180449.htm
American Society for Microbiology. "New Vaccine That Protects Monkeys Against Avian Flu Ready For Human Trials." ScienceDaily. www.sciencedaily.com/releases/2007/11/071108180449.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins